We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$113B
AUM Growth
+$3.29B
(+3%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
4,363
New
403
Increased
1,677
Reduced
1,774
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$603M |
| 2 |
Entergy
ETR
|
+$403M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
AABA
Altaba Inc
AABA
|
+$373M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$232M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$229M |
| 5 |
IBM
IBM
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.95% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
VanEck Steel ETF
SLX
$169M
| $2.95M | ﹤0.01% |
75,426
+3,896
| +5% | +$149K |
|
2127
Adaptive Biotechnologies
ADPT
$3.59B
| $2.95M | ﹤0.01% |
+61,000
| New | +$2.7M |
|
2128
NCR Voyix
VYX
$1.14B
| $2.94M | ﹤0.01% |
154,123
-5,047
| -3% | -$93.8K |
|
|
COHR
2129
DELISTED
Coherent Inc
COHR
| $2.94M | ﹤0.01% |
21,565
-728
| -3% | -$98.3K |
|
2130
PUT
EOG Resources
EOG
$79.2B
| $2.94M | ﹤0.01% |
31,500
-29,000
| -48% | -$2.7M |
|
2131
Acadia Pharmaceuticals
ACAD
$4.43B
| $2.93M | ﹤0.01% |
109,568
+19,938
| +22% | +$509K |
|
2132
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
| $2.93M | ﹤0.01% |
49,721
| – | – |
|
2133
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.09B
| $2.92M | ﹤0.01% |
+100,000
| New | +$2.89M |
|
|
ADAM
2134
Adamas Trust
ADAM
$815M
| $2.92M | ﹤0.01% |
117,620
+37,755
| +47% | +$932K |
|
|
RSX
2135
PUT
DELISTED
VanEck Russia ETF
RSX
| $2.92M | ﹤0.01% |
123,400
| – | – |
|
2136
PUT
Cleveland-Cliffs
CLF
$6.57B
| $2.9M | ﹤0.01% |
272,200
| – | – |
|
2137
iShares Dow Jones US ETF
IYY
$2.95B
| $2.89M | ﹤0.01% |
39,554
-101,724
| -72% | -$7.31M |
|
|
PSDO
2138
DELISTED
Presidio, Inc. Common Stock
PSDO
| $2.88M | ﹤0.01% |
210,752
+64,993
| +45% | +$915K |
|
|
EFOR
2139
Everforth Inc
EFOR
$1.17B
| $2.86M | ﹤0.01% |
47,254
-9,456
| -17% | -$568K |
|
2140
Minerals Technologies
MTX
$2.36B
| $2.86M | ﹤0.01% |
53,381
+20,009
| +60% | +$1.17M |
|
|
BPMC
2141
DELISTED
Blueprint Medicines
BPMC
| $2.85M | ﹤0.01% |
30,218
-11,637
| -28% | -$960K |
|
|
TSE
2142
DELISTED
Trinseo
TSE
| $2.85M | ﹤0.01% |
67,230
+10,262
| +18% | +$440K |
|
2143
BJ's Restaurants
BJRI
$1.42B
| $2.84M | ﹤0.01% |
64,691
+39,548
| +157% | +$1.81M |
|
2144
Azenta
AZTA
$1.3B
| $2.84M | ﹤0.01% |
73,273
+11,216
| +18% | +$402K |
|
2145
Ultragenyx Pharmaceutical
RARE
$2.45B
| $2.84M | ﹤0.01% |
44,727
+3,437
| +8% | +$219K |
|
2146
Enviri
NVRI
$623M
| $2.83M | ﹤0.01% |
103,249
-14,201
| -12% | -$347K |
|
2147
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.26B
| $2.83M | ﹤0.01% |
60,800
-3,844
| -6% | -$176K |
|
|
IPHI
2148
DELISTED
INPHI CORPORATION
IPHI
| $2.83M | ﹤0.01% |
56,450
+21,732
| +63% | +$1.01M |
|
2149
UMB Financial
UMBF
$11.1B
| $2.83M | ﹤0.01% |
42,946
-10,585
| -20% | -$698K |
|
|
ECHO
2150
EchoStar
ECHO
$24.4B
| $2.83M | ﹤0.01% |
78,700
+41,086
| +109% | +$1.37M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2019 Portfolio in Review
As of Q2 2019, Credit Suisse held 4,363 positions worth $113B, up 3% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2019 filing shows 403 new, 1,677 increased, 1,774 reduced and 295 closed positions. Its largest new stake was Alcon: 10,270,934 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Credit Suisse's largest Q2 2019 buy was Alcon: 10,270,934 shares worth $637M.
- Credit Suisse added most to Entergy in Q2 2019, an estimated $403M increase.
- Credit Suisse's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
- Credit Suisse fully exited iShares Core MSCI Total International Stock ETF in Q2 2019, selling an estimated $232M.
- Credit Suisse's ten largest holdings make up 17% of its $113B portfolio in Q2 2019.
- Credit Suisse opened 403 new positions and closed 295 in Q2 2019.
- Credit Suisse's portfolio value rose 3% quarter-over-quarter to $113B.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.